Veru Inc.’s mission is to improve lives through innovative science and medicine as a leading biopharmaceutical company focused on urology and oncology, while enhancing stakeholder value.

Letter from the CEO

It has been a very productive year for Veru building the foundation for growth.

Veru is now well positioned to become a leading urology and oncology biopharmaceutical company. We are focused on low cost, near- term, and high reward pharmaceuticals using an expedited regulatory pathway known as 505(b)(2). Our goal is to have several near-term and mid-term products progressing at the same time to have “multiple shots” to ensure that we file and commercialize several drugs in urology and oncology putting our company on a trajectory of solid growth.

Who We Are

Veru has assembled a first class, seasoned management team with expertise and experience in public sector as well as pharmaceutical product development and commercialization.

This team will design and implement the strategy for growth in the global public sector, pharmaceuticals and devices, and consumer health products.

FY 2018 Q4 Earnings Conference Call

December 13, 2018

Veru FY 2018 Q4 Earnings Conference Call December 13, 2018